CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
This is a Phase III, randomized, double-blind, placebo-controlled, multi-center international study assessing the activity of durvalumab and chemothe...
Phase 3
Austin, Texas, United States and 230 other locations
Cancer is a condition where cells in a specific part of body grow and reproduce uncontrollably. Non-small cell...
Phase 3
Austin, Texas, United States and 283 other locations
This Phase 3 study will evaluate the efficacy of the investigational agent MRTX849 (adagrasib) versus docetaxel in patients who have been previously...
Phase 3
Austin, Texas, United States and 262 other locations
with osimertinib in subjects with locally advanced or metastatic non-small cell lung cancer (NSCLC)....
Phase 1, Phase 2
Austin, Texas, United States and 30 other locations
in previously untreated patients with locally advanced or metastatic non-squamous Non-Small Cell Lung Ca...
Phase 3
Austin, Texas, United States and 206 other locations
Cancer is a condition where cells in a specific part of body grow and reproduce uncontrollably. Non-Small Cell...
Phase 1
Austin, Texas, United States and 27 other locations
and overall survival (OS) in patients with untreated metastatic non-small cell lung cancer with no actio...
Phase 3
Austin, Texas, United States and 220 other locations
by durvalumab in participants with untreated Locally Advanced Non-small Cell Lung Cancer (LA NSCLC)....
Phase 3
Austin, Texas, United States and 182 other locations
in combination with chemotherapy in metastatic NSCLC patients with non-squamous histology who have mutations and/or co-mutations in STK11, K...
Phase 3
Austin, Texas, United States and 83 other locations
determined to harbor oncogenic somatic mutations or positive by tumor mutational burden (TMB) assay as identified by a blood-based next...
Phase 2, Phase 3
Austin, Texas, United States and 207 other locations
Clinical trials
Research sites
Resources
Legal